00028 TIAN AN
- 3.940
- +0.040+1.03%
TIAN AN News
Cheonan New Materials (603725.SH): The product is not used in the field of flying trains
Gelonghui, May 10 丨 Tianan New Materials (603725.SH) said on the investor interactive platform that the company's main business is R&D, design, production and sales of polymer composite finishing materials such as architectural ceramics, automotive interior finishing materials, building fireproof veneer materials, home decoration materials, film, artificial leather, etc., as well as complete delivery services. Currently, the company's products are not used in the field of flying trains.
Magnesium Technology (00601.HK): Baishan Tianan Assets will be sold publicly
Magnesium Technology (00601.HK) announced that the second auction of Baishan Tianan Assets has already been auctioned off. The Group received a notice from the Baishan court that Baishan Tianan assets will be publicly sold from 10:00 on May 22, 2024 to 10:00 on July 21, 2024 (excluding delays). The starting price of the sale is approximately RMB 106 million.
Tianan New Materials (603725.SH): cumulative repurchase of 0.7255% of the company's shares
Gelonghui, May 6, 丨 Tianan New Materials (603725.SH) announced that as of April 30, 2024, the company had repurchased 1,584,200 shares of the company's shares through centralized bidding transactions, accounting for 0.7255% of the company's total share capital at present. The highest price of the repurchase transaction was 10.23 yuan/share, the lowest price was 8.63 yuan/share, and the total transaction amount was RMB 15,026,856.00 (excluding transaction fees).
Express News | Chairman Maybach Chu of the 9.9 million shooting of Hongyi next week says payment has been completed
China Medical & HealthCare Changes Name to Tian An Medicare
China Medical & HealthCare Group has changed its English name to Tian An Medicare Limited (HKG:0383), a Thursday filing on the Hong Kong bourse stated. The hospital operator's stock short name will al
China Medical Network (00383.HK) will change its name to “Tianandongjian”
China Medical Network (00383.HK) issued an announcement. Following the adoption of a special resolution by shareholders at the special shareholders' meeting held on March 1, 2024 to approve the proposed change of company name and the Registrar of Bermuda Companies issued a certificate of name change and a second name certificate on March 28, 2024, certifying that the company has changed its English name from “China Medical & Healthcare Group Limited” to “Tian An Medicare Limited” and Chinese The name is “China Medical Network
Express News | 9.9 million shots! Who bought Zhou Hongyi's Maybach? Identity revealed!
Express News | Zhou Hongyi talks about selling a used Maybach for 9.9 million: I was dumbfounded; I thought it had sold for about 1 million
天安：二零二三年年報
Express News | Tianan New Materials: Net profit of 12.265 million yuan in the first quarter of 2024 increased by 50.98% year-on-year
Cheonan (00028.HK) resumed trading on April 15
Tianan (00028.HK) announced that trading of the company's shares will resume at 9:00 a.m. on April 15, 2024.
TIAN AN To Go Ex-Dividend On April 25th, 2024 With 0.2 HKD Dividend Per Share
April 13th - $TIAN AN(00028.HK)$ is trading ex-dividend on April 25th, 2024. Shareholders of record on April 26th, 2024 will receive 0.2 HKD dividend per share on May 16th, 2024. The ex-dividend d
Tianan (00028.HK) will pay an interim dividend of HK$0.2 per share on May 16
Tianan (00028.HK) announced that the company will pay an interim dividend of HK$0.2 per share on May 16, 2024.
Tianan (00028.HK) net profit of HK$1,217 billion in 2023 decreased 20% year-on-year
Gelonghui, April 12 | Tianan (00028.HK) announced that the Group's revenue for the year ended December 31, 2023 was HK$2,782 billion, a decrease of 45% compared with last year. Profit attributable to the company's shareholders was HK$1,217 billion, a decrease of 20% compared to 2022. Earnings per share were HK$0.83 (2022: HK$1.04). At the end of 2023, the net book assets attributable to the company's shareholders was HK$18.57 (2022: HK$18.34) per share. Profit attributable to the company's shareholders for the year ended December 31, 2023 is lower than last year, some of the main issues
TIAN AN: Announcement of Audited Results for the Year 2023 and Resumption of Trading
Cheonan New Materials (603725.SH): Initial repurchase of 226,000 shares
Gelonghui, April 12, 丨 Tianan New Materials (603725.SH) announced that on April 12, 2024, the company repurchased 226,000 shares for the first time through centralized bidding. The repurchased shares accounted for 0.1035% of the company's total share capital. The highest purchase price was 10.24 yuan/share, the lowest price was 10.06 yuan/share, and the total amount paid was 2,291,512 yuan (not including transaction fees).
Tian An Australia Unveils 2023 Financial Outlook
Express News | Nine A-share companies disclosed their share repurchase plans for the first time yesterday. DaZhi, Yihe Jiaye, and Tianan New Materials repurchase plans were the most expensive
Tianan New Materials (603725.SH) plans to adjust the maximum repurchase price from 8 yuan/share to 14 yuan/share
Tianan New Materials (603725.SH) issued an announcement. In view of the recent impact of capital market conditions and changes in the company's stock price, the company's stock price recently continued to exceed the maximum repurchase price of 8 yuan/share as proposed in the plan. Based on confidence in the company's future stable development and recognition of the company's value, and also to ensure the smooth implementation of this share repurchase matter and effectively maintain the company's value and shareholders' rights, the company plans to adjust the maximum repurchase price from RMB 8 per share to RMB 14 per share. The price is no higher than the current board of directors reviewed and approved the “On Adjusting the Price of Repurchase Shares” Proposal to limit the upper limit and extend the implementation period
TIAN AN: Supplemental Announcement (1) Delay in Publication of the 2023 Annual Results; and (2) Continued Suspension of Trading
Analysis
Price Target
No Data
